Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15280343 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule
Conditions: Peripheral Arterial Disease;   Intermittent Claudication
Interventions: Drug: Danshen Gegen Capsule;   Drug: Placebo
2 Completed Blood Factors and Peripheral Arterial Disease Outcomes
Conditions: Arterial Occlusive Diseases;   Cardiovascular Diseases;   Peripheral Vascular Diseases;   Coronary Disease
Intervention:

Study has passed its completion date and status has not been verified in more than two years.